Design Therapeutics, Inc. Capital Expenditures
Design Therapeutics, Inc. (DSGN) reported Capital Expenditures of $21.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-03
- Design Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $21.00K, a 75.86% decline year-over-year.
- Design Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Design Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $34.00K.
- Design Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
- Design Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $193.00K, a 43.24% decline from fiscal 2024.
- Design Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $340.00K, a 32.81% increase from fiscal 2023.
- Design Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $256.00K, a 72.11% decline from fiscal 2022.
- Design Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $918.00K, a 40.31% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $21.00K 10-Q · filed 2026-08-03 | $55.00K derived: sum of 3 quarters · filed 2026-08-03 | $55.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $0.00 10-Q · filed 2026-04-28 | $34.00K derived: sum of 2 quarters · filed 2026-04-28 | $34.00K derived: sum of 3 quarters · filed 2026-04-28 | $121.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $34.00K derived: sum of 2 quarters · filed 2026-03-09 | $121.00K derived: sum of 3 quarters · filed 2026-08-03 | $193.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $87.00K derived: sum of 2 quarters · filed 2026-08-03 | $159.00K 10-Q · filed 2025-11-05 | $159.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $87.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $159.00K 10-Q · filed 2026-08-03 | $159.00K derived: sum of 3 quarters · filed 2026-08-03 | $143.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $72.00K 10-Q · filed 2026-04-28 | $72.00K derived: sum of 2 quarters · filed 2026-04-28 | $56.00K derived: sum of 3 quarters · filed 2026-04-28 | $217.00K derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$16.00K derived: sum of 2 quarters · filed 2026-03-09 | $145.00K derived: sum of 3 quarters · filed 2026-03-09 | $340.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $145.00K derived: sum of 2 quarters · filed 2025-11-05 | $340.00K 10-Q · filed 2025-11-05 | $367.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $356.00K 10-Q · filed 2025-08-07 | $383.00K derived: sum of 3 quarters · filed 2025-08-07 | $436.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $195.00K 10-Q · filed 2025-05-07 | $222.00K derived: sum of 2 quarters · filed 2025-05-07 | $275.00K derived: sum of 3 quarters · filed 2025-05-07 | $364.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $80.00K derived: sum of 2 quarters · filed 2025-03-10 | $169.00K derived: sum of 3 quarters · filed 2025-03-10 | $256.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $142.00K derived: sum of 2 quarters · filed 2024-11-07 | $229.00K 10-Q · filed 2024-11-07 | $517.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $89.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $176.00K 10-Q · filed 2024-08-05 | $464.00K derived: sum of 3 quarters · filed 2024-08-05 | $774.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $87.00K 10-Q · filed 2024-05-08 | $375.00K derived: sum of 2 quarters · filed 2024-05-08 | $685.00K derived: sum of 3 quarters · filed 2024-05-08 | $929.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $288.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $598.00K derived: sum of 2 quarters · filed 2024-03-19 | $842.00K derived: sum of 3 quarters · filed 2024-03-19 | $918.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | $310.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $554.00K derived: sum of 2 quarters · filed 2023-11-13 | $630.00K 10-Q · filed 2023-11-13 | $984.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $244.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $320.00K 10-Q · filed 2023-08-14 | $674.00K derived: sum of 3 quarters · filed 2023-08-14 | $1.64M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $76.00K 10-Q · filed 2023-05-09 | $430.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.40M derived: sum of 3 quarters · filed 2023-05-09 | $1.58M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $354.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.32M derived: sum of 2 quarters · filed 2023-03-14 | $1.50M derived: sum of 3 quarters · filed 2023-03-14 | $1.54M 10-K · filed 2023-03-14 |
| 2021-09-30 | $968.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.15M derived: sum of 2 quarters · filed 2022-11-03 | $1.18M 10-Q · filed 2022-11-03 | $1.20M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $216.00K 10-Q · filed 2022-08-08 | $230.00K derived: sum of 3 quarters · filed 2022-08-08 | |
| 2021-03-31 | $33.00K 10-Q · filed 2022-05-09 | $47.00K derived: sum of 2 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $76.00K 10-K · filed 2022-03-10 | ||
| 2020-09-30 | $62.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |